Interleukin-1β-Targeted Vaccine Improves Glucose Control and β-Cell Function in a Diabetic KK-Ay Mouse Model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Interleukin-1β-Targeted Vaccine Improves Glucose Control and β-Cell Function in a Diabetic KK-Ay Mouse Model

Published:2016-05-06 Issue:5 Volume:11 Page:e0154298
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Zha Jun,Chi Xiao-wei,Yu Xiao-lin,Liu Xiang-meng,Liu Dong-qun,Zhu Jie,Ji Hui,Liu Rui-tian

Funder

National Natural Science Foundation of China

National Science and Technology Major Projects of New Drugs

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference30 articles.

1. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes;AE Butler;Diabetes,2003

2. Modulating an oxidative-inflammatory cascade: potential new treatment strategy for improving glucose metabolism, insulin resistance, and vascular function;RE Lamb;International journal of clinical practice,2008

3. Targeting inflammation in the treatment of type 2 diabetes: time to start;MY Donath;Nature reviews Drug discovery,2014

4. Autophagy defends pancreatic beta cells from human islet amyloid polypeptide-induced toxicity;JF Rivera;The Journal of clinical investigation,2014

5. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance;B Vandanmagsar;Nature medicine,2011

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Vaccination Practice in Diabetic (Diabetes I) Patients;Current Diabetes Reviews;2023-10-06

2. Mechanism of immune attack in the progression of obesity-related type 2 diabetes;World Journal of Diabetes;2023-05-15

3. Macrophages: A rising star in immunotherapy for chronic pancreatitis;Pharmacological Research;2022-11

4. Vaccine for Diabetes—Where Do We Stand?;International Journal of Molecular Sciences;2022-08-22

5. Focus on the Lymphatic Route to Optimize Drug Delivery in Cardiovascular Medicine;Pharmaceutics;2021-08-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3